Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
RIPK3 and kidney disease
Juan Guerrero-Mauvecin; Miguel Fontecha-Barriuso; Ana M. López-Diaz; Alberto Ortiz; Ana B. Sanz;
Nefrologia (English Version). 2024;44:10-22
Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease
Mariana Morais David Pliças; Bernardo Marques da Silva; Edgar Avito Fernandes de Almeida;
Nefrologia (English Version). 2025;45:214-27
Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project
Juan F. Navarro González; Alberto Ortiz; Ana Cebrián Cuenca; Marta Moreno Barón; Lluís Segú; Belén Pimentel; Unai Aranda; Blanca Lopez-Chicheri; Margarita Capel; Elisenda Pomares Mallol; Christian Caudron; Juan José García Sánchez; Roberto Alcázar Arroyo;
Nefrologia (English Version). 2024;44:807-17